Supernus Pharmaceuticals (SUPN) Goodwill (2020 - 2026)

Supernus Pharmaceuticals (SUPN) has 7 years of Goodwill data on file, last reported at $120.7 million in Q1 2026.

• On a quarterly basis, Goodwill rose 3.12% year-over-year to $120.7 million in Q1 2026; TTM through Mar 2026 was $120.7 million, a 3.12% increase from a year earlier, with the FY2025 full-year figure at $124.9 million, up 6.72% from the prior year.
• Goodwill for Q1 2026 stood at $120.7 million, down from $124.9 million in the prior quarter.
• Over the last five years, Goodwill for SUPN reached as high as $124.9 million in Q4 2025 and fell as low as $115.4 million in Q1 2022.
• Historically, Goodwill has averaged $117.6 million across 5 years, with a median of $117.0 million in 2022.
• On a YoY basis, Goodwill climbed as much as 50.56% in 2022 and fell as far as 0.42% in 2022.
• Year by year, Goodwill stood at $117.0 million in 2022, then changed by 0.0% to $117.0 million in 2023, then changed by 0.0% to $117.0 million in 2024, then grew by 6.72% to $124.9 million in 2025, then dropped by 3.37% to $120.7 million in 2026.
• Per Business Quant data, the three most recent Goodwill figures were $120.7 million in Q1 2026, $124.9 million in Q4 2025, and $119.1 million in Q3 2025.